February 19, 2026
According to market projections, the vaccine adjuvant sector is expected to grow from USD 747.6 million in 2025 to USD 1394.15 million by 2035, reflecting a CAGR of 6.43%.The market is growing due to rising demand for stronger and longer-lasting im...
April 16, 2026
Vaccines Market (By Vaccine Type:Subunit/conjugate/recombinant protein vaccines, mRNA & other nucleic-acid vaccines, Live attenuated vaccines, Inactivated/killed vaccines, Viral-vector vaccines, VLPs & peptide vaccines, Therapeutic vaccines...
April 21, 2026
According to forecasts, the global TD vaccine market will grow from USD 6.17 billion in 2024 to USD 10.68 billion by 2034, with an expected CAGR of 5.64%. Increasing global health programs and the development of combination vaccines are fueling deman...
April 21, 2026
Market insights predict, the dengue vaccine industry is expected to grow from USD 751.01 million in 2025 to USD 2297.33 million by 2035, driven by a CAGR of 11.74%. The dengue vaccine market is growing due to a rise in government initiatives to promo...
April 21, 2026
The cell-based vaccine market is growing due to rising demand for personalized medicine. North America dominance is due to growing investment by the government in cell-based vaccines....
January 28, 2026
According to our projections, the thermostable vaccine sector is expected to grow from USD 9.27 billion in 2025 to USD 19.05 billion by 2035, reflecting a CAGR of 7.47%. The thermostable vaccine market is growing fast, driven by the need for heat-res...
April 21, 2026
According to market projections, the global respiratory disease vaccine market, valued at USD 65.72 billion in 2025, is anticipated to reach USD 98.41 billion by 2035, growing at a CAGR of 4.12% over the next decade. The rising prevalence of respirat...
April 10, 2026
Personalized Cancer Vaccine Market (By Vaccine Type: Neoantigen-Based Vaccines, Dendritic Cell Vaccines, Tumor Cell Vaccines, Viral Vector-Based Vaccines; By Cancer Type: Melanoma, Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Other...
April 21, 2026
The mRNA Quality Monitoring market is projected to grow from USD 1.37 billion in 2025 to USD 2.5 billion by 2034, expanding at a CAGR of 6.97%. This report provides a full overview of market size, segmentation, and competitive analysis, covering all ...
February 26, 2026
Based on our forecasts, the consumption-type vaccine sector will expand from USD 10.9 billion in 2025 to USD 33.16 billion by 2035, experiencing a CAGR of 11.77%. The global market is growing due to rising infectious diseases, increased vaccination a...
April 21, 2026
Projections indicate that, the global HIV clinical trials market will increase from USD 1.27 billion in 2024 to USD 2.54 billion by 2034, experiencing a CAGR of 7.17% over the next 10 years. The HIV clinical trials market is expanding due to growing ...
February 12, 2026
The mRNA vaccine raw materials market is projected to reach several hundred million dollars by 2035, expanding steadily from 2026 onward due to rising demand for infectious disease and oncology vaccines....
April 21, 2026
Various usage of kidney fibroblast cell lines in different fields of life science are driving the baby hamster kidney fibroblast cells market. North America is leading in the market due to rising investment in animal cell research....
March 09, 2026
The global animal vaccine market, valued at USD 18.99 billion in 2025, is anticipated to reach USD 49.24 billion by 2035, growing at a CAGR of 10% over the next decade. An animal vaccine is a medicine that helps protect animals from diseases by boost...
April 21, 2026
The development of better immunity against the growing variants of COVID-19 viruses promotes the growth of the next-gen COVID-19 vaccine market. North America is dominating the market due to the growing research on next-generation vaccines....
April 21, 2026
According to forecasts, the Japan cell cancer vaccine market will grow from USD 320.6 million in 2024 to USD 576.4 million by 2034, with an expected CAGR of 6.04%. The Japan cell cancer vaccine market is expanding due to rising incidences of cancer a...
April 21, 2026
According to market projections, the influenza vaccine sector is expected to grow from USD 8.49 billion in 2024 to USD 16.73 billion by 2034, reflecting a CAGR of 7.02%. In 2024, North America led the influenza vaccine market (53% share), with Asia P...
April 02, 2026
Valves in Pharmaceutical Market (By Valve Type: Diaphragm Valves, Ball Valves, Butterfly Valves, Control Valves, Check & Safety Valves, Others; By Material: Stainless Steel, Alloys, Polymers & Plastics, Other Materials; By Application: Tradit...
April 21, 2026
According to market projections, the global continuous bioprocessing market, valued at USD 349.32 million in 2024, is anticipated to reach USD 1933.16 million by 2034, growing at a CAGR of 18.66% over the next decade. The continuous bioprocessing mar...
April 21, 2026
The Hepatitis A vaccine market, valued at US$ 759.01 million in 2024, is projected to reach US$ 948.16 million by 2034. Growth is driven by rising outbreaks, immunization awareness, and travel. Asia-Pacific leads, with North America growing fastest...
April 21, 2026
Market insights predict, the viral vaccine cell culture media industry is expected to grow from USD 1.83 billion in 2024 to USD 3.24 billion by 2034, driven by a CAGR of 5.84%. Viral vaccines are in high demand due to rising cases of viral infections...
April 21, 2026
According to market projections, the DNA vaccine sector is expected to grow from USD 553.89 million in 2024 to USD 1041.68 million by 2034, reflecting a CAGR of 6.52%. In 2024, North America led the global DNA vaccine market, with Asia-Pacific expect...
April 21, 2026
According to market projections, the global biological inactivated vaccine market, valued at USD 0.95 billion in 2024, is anticipated to reach USD 1.57 billion by 2034, growing at a CAGR of 5.14% over the next decade.The rising prevalence of infect...
April 21, 2026
Market insights predict the global polio vaccine industry will increase from USD 861.25 million in 2024 to USD 1406.89 million by 2034, achieving a CAGR of 5.03%. In 2024, North America led the polio vaccine market, with Asia-Pacific set for rapid gr...
April 21, 2026
Projections indicate that, progressive pulmonary fibrosis (PPF) treatment industry is projected to rise from USD 0.6 billion in 2024 to USD 2.45 billion by 2034, reflecting a CAGR of 15.21% over the next decade. The Progressive Pulmonary Fibrosis (PP...
April 21, 2026
The seasonal vaccines market is expanding due to growing government initiatives as well as rising post-pandemic awareness. North America led the market due to the high healthcare investments....
April 21, 2026
The cholera vaccines market size is calculated at $103.99 mn in 2025 is to hit $246 mn by 2034. In early 2025, Nakonde, Zambia, launched a cholera vaccination campaign targeting 191,153 people. In October 2024, India’s ICMR and NIRBD began a pi...
April 21, 2026
Based on market forecasts, the bladder cancer vaccines market was valued at USD 370.2 million in 2025 and is expected to grow from USD 456.83 million in 2026 to approximately USD 3,031.01 million by 2035, registering a strong CAGR of 23.4% during 202...
April 21, 2026
According to market projections, the rotavirus vaccines market was valued at USD 5.25 billion in 2025 and is projected to grow from USD 5.78 billion in 2026 to USD 13.79 billion by 2035, registering a CAGR of 10.14% during the forecast period. The re...
February 26, 2026
Market insights predict, the RNA therapeutics and vaccines industry is expected to grow from USD 0.39 billion in 2025 to USD 205.34 billion by 2035, driven by a CAGR of 87%. The RNA therapeutics and vaccines market is growing as it is an innovative a...
April 30, 2026
Poultry Vaccines Market (By Product Type: Live Vaccines, Inactivated / Killed Vaccines, Recombinant / Vector-Based Vaccines, Subunit / Protein-Based Vaccines; By Deployment Type: On-Farm Administration, Veterinary Clinic / Hospital-Based, Hybrid / Co...
April 21, 2026
According to market projections, the cancer vaccines sector is expected to grow from USD 11.38 billion in 2024 to USD 33.61 billion by 2034, reflecting a CAGR of 11.44%. The increasing prevalence of cancer, research and development and continuous eff...
April 01, 2026
Veterinary Vaccines Market (By Animal Type: Production Animals, Poultry vaccines, Companion Animals, Aquaculture, Other Livestock, Wildlife / Zoo & Equine specialty; By Vaccine Type / Technology: Live-Attenuated Vaccines, Inactivated Vaccines, Re...
March 25, 2026
Meningococcal Vaccines Market (By Type: Bivalent, Quadrivalent, Others, By Brand: Menactra, Menveo, Nimenrix, Trumenba, Bexsero, Others; By Serotye: A, B, C, W-135, Y; By Age Group: Infants (0 to 2 years), Children and Adults (2 years and above); By ...
April 21, 2026
According to market projections, the antimalarial drugs sector is expected to grow from USD 1.07 billion in 2024 to USD 1.67 billion by 2034, reflecting a CAGR of 4.57%. Establishing awareness and government programs are propelling the global market ...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com